How to identify a reclassification candidate and prepare for the early stages of the reclassification procedure

This guidance provides an overview of what companies should consider when evaluating a potential switch candidate and how to scope and prepare for the early stages of reclassification process, including how to prepare and engage with MHRA via scientific advice meetings.

The guidance covers:

  • Company requirements
  • Selection and assessment of potential reclassification candidates
  • Building your product profile
  • Liaison with MHRA

This content is exclusively for PAGB members.

Please login to your PAGB website account to access this content. Or visit our membership pages to find out more about PAGB membership and how you could benefit from our collective and expert voice representing and promoting the sector’s interests.

OTC medicines hub

Here you will find all information relevant to OTC medicines, from codes and guidance, to training workshops.

Visit hub